SCHEMBL2725317

SCHEMBL2725317

CC1CCCC1OC(=O)C1(N)CCOCC1

nearest known ligand 0.33

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.33
ALDH1A1 P00352 2/20 0.32
TSHR P16473 2/20 0.32
MAPK1 P28482 2/20 0.32
HTT P42858 2/20 0.32
RAB9A P51151 2/20 0.32
LMNA P02545 1/20 0.32
NPC1 O15118 1/20 0.31
TP53 P04637 1/20 0.31
MAPT P10636 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10072546 0.76 CYP2C19 (0.38)
SCHEMBL971209 0.73 CYP3A4 (0.41) ALDH1A1LMNANPSR1
Hydrochloric Acid SCHEMBL1818830 0.71 CYP2C19 (0.41) ALDH1A1TSHRLMNANPSR1
SCHEMBL1808291 0.70 CYP3A4 (0.38) ALDH1A1NPSR1
Hydrochloric Acid SCHEMBL1808290 0.69 CYP3A4 (0.37) ALDH1A1NPSR1
SCHEMBL23785933 0.69 EPHX1 (0.43) CYP19A1ALDH1A1TSHRMAPK1HTT
SCHEMBL19571007 0.69 EPHX1 (0.43) CYP19A1ALDH1A1TSHRMAPK1HTT
SCHEMBL19570983 0.69 EPHX1 (0.43) CYP19A1ALDH1A1TSHRMAPK1HTT
SCHEMBL10082464 0.69 EPHX1 (0.43) CYP19A1ALDH1A1TSHRMAPK1HTT
SCHEMBL19570986 0.69 EPHX1 (0.43) CYP19A1ALDH1A1TSHRMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012025701-A1 ALPHA, ALPHA - DI SUBSTITUTED GLYCINE ESTER DERIVATIVES AND THEIR USE AS HDAC INHIBITORS CHROMA THERAPEUTICS LTD. (GB) 2012-03-01 WO disclosed
WO-2012025701-A1 ALPHA, ALPHA - DI SUBSTITUTED GLYCINE ESTER DERIVATIVES AND THEIR USE AS HDAC INHIBITORS CHROMA THERAPEUTICS LTD. (GB) 2012-03-01 WO disclosed